Esperion Therapeutics, Inc. (ESPR)

Esperion Therapeutics Statistics

Total Valuation

ESPR has a market cap or net worth of $944.08 million. The enterprise value is $1.45 billion.

Market Cap	944.08M
Enterprise Value	1.45B

Important Dates

The last earnings date was Thursday, November 6, 2025, before market open.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

ESPR has 235.43 million shares outstanding. The number of shares has increased by 18.70% in one year.

Current Share Class	235.43M
Shares Outstanding	235.43M
Shares Change (YoY)	+18.70%
Shares Change (QoQ)	+1.61%
Owned by Insiders (%)	0.69%
Owned by Institutions (%)	47.15%
Float	233.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	13.28
PS Ratio	2.61
Forward PS	1.92
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	4.78
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.00

Current Ratio	1.00
Quick Ratio	0.59
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-0.37

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-5.42%
Return on Invested Capital (ROIC)	-10.83%
Return on Capital Employed (ROCE)	-589.13%
Revenue Per Employee	$999,349
Profits Per Employee	-$348,128
Employee Count	304
Asset Turnover	0.90
Inventory Turnover	1.55

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +57.87% in the last 52 weeks. The beta is 1.04, so ESPR's price volatility has been similar to the market average.

Beta (5Y)	1.04
52-Week Price Change	+57.87%
50-Day Moving Average	2.86
200-Day Moving Average	1.81
Relative Strength Index (RSI)	75.10
Average Volume (20 Days)	7,416,548

Short Selling Information

The latest short interest is 24.96 million, so 10.60% of the outstanding shares have been sold short.

Short Interest	24.96M
Short Previous Month	25.92M
Short % of Shares Out	10.60%
Short % of Float	10.67%
Short Ratio (days to cover)	4.16

Income Statement

In the last 12 months, ESPR had revenue of $303.80 million and -$105.83 million in losses. Loss per share was -$0.54.

Revenue	303.80M
Gross Profit	131.90M
Operating Income	-29.38M
Pretax Income	-105.83M
Net Income	-105.83M
EBITDA	-29.27M
EBIT	-29.38M
Loss Per Share	-$0.54

Balance Sheet

The company has $92.45 million in cash and $600.99 million in debt, giving a net cash position of -$508.54 million or -$2.16 per share.

Cash & Cash Equivalents	92.45M
Total Debt	600.99M
Net Cash	-508.54M
Net Cash Per Share	-$2.16
Equity (Book Value)	-451.36M
Book Value Per Share	-2.20
Working Capital	1.43M

Cash Flow

Operating Cash Flow	-93.29M
Capital Expenditures	n/a
Free Cash Flow	-93.29M
FCF Per Share	-$0.40

Margins

Gross margin is 43.42%, with operating and profit margins of -9.67% and -34.84%.

Gross Margin	43.42%
Operating Margin	-9.67%
Pretax Margin	-34.84%
Profit Margin	-34.84%
EBITDA Margin	-9.64%
EBIT Margin	-9.67%
FCF Margin	n/a

Dividends & Yields

ESPR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.70%
Shareholder Yield	-18.70%
Earnings Yield	-11.21%
FCF Yield	-9.88%

Analyst Forecast

The average price target for ESPR is $6.86, which is 71.07% higher than the current price. The consensus rating is "Buy".

Price Target	$6.86
Price Target Difference	71.07%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	29.13%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ESPR has an Altman Z-Score of -5.65 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.65
Piotroski F-Score	2